Symetis  	Symetis  	 NNP	B-NP
ACURATE  	ACURATE  	 NNP	I-NP
TA  	TA  	 NNP	I-NP
valve  	valve  	 VBD	I-NP
The  	The  	 DT	O
transcatheter  	transcatheter  	 FW	B-NP
aortic  	aortic  	 FW	I-NP
valve  	valve  	 FW	I-NP
prosthesis  	prosthesis  	 FW	I-NP
ACURATE  	ACURATE  	 NNP	I-NP
TA  	TA  	 NNP	I-NP
( 	( 	 -LRB-	O
Symetis  	Symetis  	 NNP	B-NP
SA 	SA 	 NNP	O
,  	,  	 ,	O
Ecublens 	Ecublens 	 NNP	B-NP
,  	,  	 ,	O
Switzerland 	Switzerland 	 NNP	B-NP
)  	)  	 -RRB-	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
specifically  	specifically  	 RB	O
designed  	designed  	 VBN	O
for  	for  	 IN	O
transapical  	transapical  	 JJ	B-NP
access  	access  	 NN	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
future  	future  	 JJ	O
transfemoral  	transfemoral  	 JJ	B-NP
version  	version  	 NN	I-NP
under  	under  	 IN	O
development 	development 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
concept  	concept  	 NN	O
relies  	relies  	 VBZ	O
on  	on  	 IN	O
a  	a  	 DT	O
self-expandable  	self-expandable  	 JJ	B-NP
nitinol  	nitinol  	 JJ	I-NP
stent  	stent  	 JJ	I-NP
housing  	housing  	 NN	I-NP
a  	a  	 DT	O
regular  	regular  	 JJ	B-NP
porcine  	porcine  	 JJ	I-NP
bioprosthesis 	bioprosthesis 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
unique  	unique  	 JJ	O
two-step  	two-step  	 JJ	B-NP
implantation  	implantation  	 FW	I-NP
technique  	technique  	 FW	I-NP
facilitates  	facilitates  	 FW	O
intuitive  	intuitive  	 FW	O
positioning 	positioning 	 FW	O
.  	.  	 .	O
Two  	Two  	 CD	O
pre-approval  	pre-approval  	 JJ	B-NP
multicentre  	multicentre  	 JJ	I-NP
trials  	trials  	 NNS	I-NP
have  	have  	 VBP	O
demonstrated  	demonstrated  	 VBN	O
promising  	promising  	 JJ	O
results  	results  	 NNS	O
especially  	especially  	 RB	O
as  	as  	 RB	O
regards  	regards  	 VBZ	O
a  	a  	 DT	O
low  	low  	 JJ	O
rate  	rate  	 NN	O
of  	of  	 IN	O
paravalvular  	paravalvular  	 JJ	B-NP
leaks 	leaks 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
device  	device  	 NN	O
obtained  	obtained  	 VBD	B-NP
CE  	CE  	 NNP	I-NP
mark  	mark  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
2011  	2011  	 CD	O
and  	and  	 CC	O
is  	is  	 VBZ	O
currently  	currently  	 RB	O
commercially  	commercially  	 RB	O
available  	available  	 JJ	O
in  	in  	 IN	O
Europe 	Europe 	 NNP	O
.  	.  	 .	O
This  	This  	 DT	O
manuscript  	manuscript  	 NN	O
focuses  	focuses  	 VBZ	O
on  	on  	 IN	O
the  	the  	 DT	O
technical  	technical  	 JJ	B-NP
details  	details  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
new  	new  	 JJ	O
transapical  	transapical  	 JJ	B-NP
TAVI  	TAVI  	 NNP	I-NP
device  	device  	 NN	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
specific  	specific  	 JJ	O
implantation  	implantation  	 JJ	B-NP
technique 	technique 	 NN	I-NP
.  	.  	 .	O
